141 related articles for article (PubMed ID: 19622306)
21. The use of FDG-PET in the detection and management of malignant lymphoma: correlation of uptake with prognosis.
Okada J; Yoshikawa K; Imazeki K; Minoshima S; Uno K; Itami J; Kuyama J; Maruno H; Arimizu N
J Nucl Med; 1991 Apr; 32(4):686-91. PubMed ID: 2013808
[TBL] [Abstract][Full Text] [Related]
22. Opportunities and limitations of bone marrow biopsy and bone marrow FDG-PET in lymphoma.
Adams HJ; Nievelstein RA; Kwee TC
Blood Rev; 2015 Nov; 29(6):417-25. PubMed ID: 26113144
[TBL] [Abstract][Full Text] [Related]
23. Whole-Body Diffusion-weighted MR Imaging of Iron Deposits in Hodgkin, Follicular, and Diffuse Large B-Cell Lymphoma.
Cottereau AS; Mulé S; Lin C; Belhadj K; Vignaud A; Copie-Bergman C; Boyez A; Zerbib P; Tacher V; Scherman E; Haioun C; Luciani A; Itti E; Rahmouni A
Radiology; 2018 Feb; 286(2):560-567. PubMed ID: 28985135
[TBL] [Abstract][Full Text] [Related]
24. Relationship between FDG uptake and expressions of glucose transporter type 1, type 3, and hexokinase-II in Reed-Sternberg cells of Hodgkin lymphoma.
Shim HK; Lee WW; Park SY; Kim H; Kim SE
Oncol Res; 2009; 17(7):331-7. PubMed ID: 19408578
[TBL] [Abstract][Full Text] [Related]
25. Whole-Body Diffusion-weighted Imaging in Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma.
Toledano-Massiah S; Luciani A; Itti E; Zerbib P; Vignaud A; Belhadj K; Baranes L; Haioun C; Lin C; Rahmouni A
Radiographics; 2015; 35(3):747-64. PubMed ID: 25815803
[TBL] [Abstract][Full Text] [Related]
26. Correlation of fluorodeoxyglucose uptake and tumor-proliferating antigen Ki-67 in lymphomas.
Shou Y; Lu J; Chen T; Ma D; Tong L
J Cancer Res Ther; 2012; 8(1):96-102. PubMed ID: 22531522
[TBL] [Abstract][Full Text] [Related]
27. [Mode of spread and terminal of disease in malignant lymphoma after radiation therapy (author's transl)].
Kiyono K; Wako T; Ohata T; Watanabe T; Kobayashi T
Nihon Igaku Hoshasen Gakkai Zasshi; 1978 Jun; 38(6):539-46. PubMed ID: 358137
[No Abstract] [Full Text] [Related]
28. Metabolic activity measured by F-18 FDG PET in natural killer-cell lymphoma compared to aggressive B- and T-cell lymphomas.
Chan WK; Au WY; Wong CY; Liang R; Leung AY; Kwong YL; Khong PL
Clin Nucl Med; 2010 Aug; 35(8):571-5. PubMed ID: 20631501
[TBL] [Abstract][Full Text] [Related]
29. [Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in the treatment of Hodgkin's disease and malignant non-Hodgkin's lymphoma].
Bourguet P;
Bull Cancer; 2003 Feb; 90 Spec No():S88-95. PubMed ID: 12739340
[No Abstract] [Full Text] [Related]
30. Non-Hodgkin lymphoma dominated by multiple organ extranodal disease revealed on FDG PET/CT.
Bai X; Codreanu I; Kaplan SL; Servaes S; Zhuang H
Clin Nucl Med; 2015 Apr; 40(4):360-3. PubMed ID: 25608171
[TBL] [Abstract][Full Text] [Related]
31. Testicular FDG-PET/CT uptake threshold in aggressive lymphomas.
Higgins A; Kim H; Harper L; Habermann TM; Nowakowski GS; Thompson CA; Johnston P; Witzig TE; Allmer C; Maurer MJ; Cerhan JR; Young JR; Thanarajasingam G
Am J Hematol; 2021 Mar; 96(3):E81-E83. PubMed ID: 33338288
[No Abstract] [Full Text] [Related]
32. [F-18]-Fluoro-2-deoxy-D: -glucose positron emission tomography as a tool for early detection of immunotherapy response in a murine B cell lymphoma model.
Chaise C; Itti E; Petegnief Y; Wirquin E; Copie-Bergman C; Farcet JP; Delfau-Larue MH; Meignan M; Talbot JN; Molinier-Frenkel V
Cancer Immunol Immunother; 2007 Aug; 56(8):1163-71. PubMed ID: 17171356
[TBL] [Abstract][Full Text] [Related]
33. Diffuse bone marrow involvement of Hodgkin lymphoma mimics hematopoietic cytokine-mediated FDG uptake on FDG PET imaging.
Chiang SB; Rebenstock A; Guan L; Alavi A; Zhuang H
Clin Nucl Med; 2003 Aug; 28(8):674-6. PubMed ID: 12897658
[TBL] [Abstract][Full Text] [Related]
34. Positron emission tomography/computed tomography after immunocytochemical and clonal diagnosis of intraocular lymphoma with vitrectomy cell blocks.
Matsuo T; Ichimura K; Ichikawa T; Okumura Y; Kaji M; Yoshino T
J Clin Exp Hematop; 2009 Nov; 49(2):77-87. PubMed ID: 19907112
[TBL] [Abstract][Full Text] [Related]
35. The role of PET imaging in lymphoma.
Burton C; Ell P; Linch D
Br J Haematol; 2004 Sep; 126(6):772-84. PubMed ID: 15352980
[TBL] [Abstract][Full Text] [Related]
36. Crossed cerebellar diaschisis due to cerebral diffuse large B cell lymphoma on 18F-FDG PET/CT.
Teoh EJ; Green AL; Bradley KM
Int J Hematol; 2014 Nov; 100(5):415-6. PubMed ID: 25119023
[No Abstract] [Full Text] [Related]
37. Comparison of CT, PET, and PET/CT for staging of patients with indolent non-hodgkin's lymphoma: statistical errors in Fueger et al. (2009).
White LR
Mol Imaging Biol; 2012 Aug; 14(4):397-8; author reply 399-401. PubMed ID: 21814856
[No Abstract] [Full Text] [Related]
38. Differential FDG accumulation associated with GLUT-1 expression in a patient with lymphoma.
Koga H; Matsuo Y; Sasaki M; Nakagawa M; Kaneko K; Hayashi K; Kuwabara Y; Honda H
Ann Nucl Med; 2003 Jun; 17(4):327-31. PubMed ID: 12932118
[TBL] [Abstract][Full Text] [Related]
39. Prospective study of 18F-FDG PET in pediatric mediastinal lymphoma: a single center experience.
Edeline V; Bonardel G; Brisse H; Foehrenbach H; Pacquement H; Maszelin P; Gaillard JF; Michon J; Neuenschwander S
Leuk Lymphoma; 2007 Apr; 48(4):823-6. PubMed ID: 17454646
[No Abstract] [Full Text] [Related]
40. Focal and diffuse FDG uptake patterns of endotracheal lymphoma.
Dong A; Zhao T; Wang Y; Zuo C
Clin Nucl Med; 2014 Aug; 39(8):731-5. PubMed ID: 24217549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
